STING activation leads to CD8+ T cell tumor infiltration and has also been shown to enhance the upregulation of adhesion molecules (e.g., ICAM1 and VCAM1) on ECs, alterations that altogether promote anti-cancer immune responses. Here, CD8A is linked to neoplasm.